1D
0.78%
0.4%
1W
-6.55%
-0.12%
1M
9.73%
2.57%
YTD
105%
9.55%
1Y
105%
4.69%
3Y
129.46%
36.24%
5Y
232.2%
89.9%
10Y
15.66%
233.89%
- Stock Absolute Returns
- Absolute Returns
Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
19.39%
0%
19.39%
6 Months
136.78%
0%
136.78%
1 Year
105.0%
0%
105.0%
2 Years
120.55%
0%
120.55%
3 Years
129.46%
0%
129.46%
4 Years
159.23%
0%
159.23%
5 Years
232.2%
0%
232.2%
Concord Drugs for the last several years.
What is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers 
Inconsistent Performance
Concord Drugs Ltd has not been a consistent performer in the YTD and longer periods
1
Quartile
QTD
15.89%
1
Quartile
Jun-Sep
61.27%
1
Quartile
Mar-Jun
33.2%
1
Quartile
YTD
103.42%
4
Quartile
2024
-36.37%
1
Quartile
2023
83.47%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry 
Inconsistent Performance
Concord Drugs Ltd has not been a consistent performer in the YTD and longer periods
1
Quartile
QTD
15.89%
1
Quartile
Jun-Sep
61.27%
1
Quartile
Mar-Jun
33.2%
1
Quartile
YTD
103.42%
4
Quartile
2024
-36.37%
1
Quartile
2023
83.47%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap 
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available






